Term	es	nes	pval	sidak	fdr	geneset_size	leading_edge	leading_edge_size
Glycosaminoglycan degradation	0.9228496388706512	2.7378280277947264	0.0061846407359877	0.9764144793748842	0.6617942144649182	7	P54802,P16278,P06865,P07686,P15586,Q9Y251	6
Degradation pathway of sphingolipids including diseases	0.918176921335358	2.7176812004862665	0.0065741147132276	0.9813866256899212	0.6617942144649182	7	P16278,P06865,P06280,Q99519,P17900	5
Sphingolipid metabolism in senescence	0.7860367113959864	2.6080363208706845	0.0091063291357884	0.9960158022295365	0.6916285996335741	11	P04062,P16278,Q06136,Q96G23,O15269,Q16739,Q13510	7
Sphingolipid pathway	0.7681166841316929	2.517807474379978	0.011808784933323	0.9992344788511798	0.6916285996335741	11	P04062,Q96G23,Q8TCT0,Q9NRX5,O95470,O15269,Q16739,Q13510	8
Sphingolipid metabolism integrated pathway	0.8101585878516483	2.5127246345874705	0.0119802806202984	0.9993106655688672	0.6916285996335741	9	Q96G23,Q8TCT0,O95470,O15269,Q16739,P27544,Q13510	7
Sphingolipid metabolism overview	0.8101585878516483	2.5127246345874705	0.0119802806202984	0.9993106655688672	0.6916285996335741	9	Q96G23,Q8TCT0,O95470,O15269,Q16739,P27544,Q13510	7
1q211 copy number variation syndrome	0.7359136683713818	2.2927086563352597	0.0218647838458403	0.9999984116992904	0.6916285996335741	10	Q9Y624,Q96J84,Q16625	3
Mitochondrial complex iv assembly	0.6839113030010858	2.211205061466438	0.0270216400512941	0.9999999347889108	0.6916285996335741	13	P14406,Q7KZN9,Q15526,Q9Y2R0,P13073	5
Metabolism of spingolipids in er and golgi apparatus	0.8513779527558962	2.056782572530976	0.0397071451874799	0.9999999999764584	0.6916285996335741	5	O95470,Q10472,Q8TCT0,Q16739	4
Calcium regulation in cardiac cells	0.5594672463939526	1.9909049958768896	0.0464913328711149	0.9999999999996748	0.6916285996335741	21	P10644,P54709,P17612,P62942,P16615,P04899,P0DP25,P20020	8
Statin inhibition of cholesterol production	0.7529432768663223	1.97157685524165	0.0486579314789483	0.9999999999999176	0.6916285996335741	7	Q8WTV0,Q07954,P04114,P01130,Q14534	5
Familial hyperlipidemia type 3	0.88356838307641	1.9486147253832744	0.0513414522632305	0.999999999999985	0.6916285996335741	4	Q07954,P98155,P01130	3
Proteoglycan biosynthesis	0.8823911026115598	1.9438521242940396	0.051913285986443	0.9999999999999896	0.6916285996335741	4	Q8TB61,Q9NX62	2
Hippo signaling regulation pathways	0.5742622947644551	1.8850352183498045	0.0594250831327893	1.0	0.6916285996335741	17	P10644,P19022,P17612,P42345,P00533,P08069,P04899	7
Genes controlling nephrogenesis	0.6753140239764424	1.8450522711262227	0.0650299352382175	1.0	0.6916285996335741	9	Q9Y5K6,P05556,Q12948,O94813,Q96J84	5
Complement system in neuronal development and plasticity	0.6285271190288262	1.8349349243814	0.0665153322017713	1.0	0.6916285996335741	12	P15529,P06756,Q5KU26,Q08431	4
Glycerophospholipid biosynthetic pathway	0.7415850803246935	1.8170541231842692	0.0692088264319743	1.0	0.6916285996335741	6	Q9BTU6,O14735	2
Development of ureteric collection system	0.7388664011922723	1.8043912867937328	0.0711699880295513	1.0	0.6916285996335741	6	Q5SZK8,O94813	2
Electron transport chain oxphos system in mitochondria	0.5038438632053917	1.7978697078859232	0.0721976575120817	1.0	0.6916285996335741	50	O14949,P13073,P12235,O75964,P12236,P14406,P05141,O96000,Q9Y6M9,Q7KZN9,P00403,Q9UDW1,O43676,Q15526,P03886,O75438,O95169,P03915	18
Kennedy pathway from sphingolipids	0.7831364829396239	1.7619430999855912	0.0780789115965101	1.0	0.6916285996335741	5	O95470,P35790,Q9UG56,P48651	4
Proximal tubule transport	0.658326133858625	1.7571950399294558	0.0788845704262055	1.0	0.6916285996335741	9	P08195,P04920,P36543,P11166	4
Alzheimers disease and mirna effects	0.3833087008892544	1.7135357707050087	0.086614018414834	1.0	0.6916285996335741	82	P12235,P49721,P12236,P45880,O95197,P16615,Q92542,P60900,Q07954,P21796,Q9Y277,Q9NQC3,P05067,P31751	14
Ferroptosis	0.5179930125711968	1.693192598146867	0.0904188130456642	1.0	0.6916285996335741	22	Q9NZ45,Q96QD8,P02786,P09601,P45880,P08195,P16435,Q9Y277	8
Nonalcoholic fatty liver disease	0.4965094628667714	1.6813972863225664	0.0926857722879215	1.0	0.6916285996335741	47	O14949,O95169,P14406,O96000,Q9Y6M9,P00403,Q9P0J0,Q86Y39,Q9UDW1,O43676,P31751,Q96J02,O75438,P13073	14
Alzheimers disease	0.3835858807736104	1.6566014271427512	0.0976000836388382	1.0	0.6916285996335741	81	P12235,P49721,P12236,P45880,O95197,P16615,Q92542,P60900,Q07954,P21796,Q9Y277,Q9NQC3,P05067,P31751	14
Ebola virus infection in host	0.4966134963692284	1.6523165858379032	0.0984700299248744	1.0	0.6916285996335741	45	P20339,O75569,P61916,O15118,P10321,P06756,P01889,P04439,P05556,Q07021,P00533,Q08431,P51149,P07858,P51151	15
Oxidation by cytochrome p450	0.8091177435224507	1.6435493097303682	0.1002693319178882	1.0	0.6916285996335741	4	P16435,O43169,Q16850	3
Copper homeostasis	0.6599297436731786	1.6405784883398211	0.1008849434303271	1.0	0.6916285996335741	8	P05067	1
Endothelin pathways	0.656411329159041	1.6227570606422237	0.1046413481888117	1.0	0.6916285996335741	8	P16615,P42892	2
Insulin signaling in adipocytes diabetic condition	0.7492928052531338	1.6127360987528714	0.1068018542966657	1.0	0.6916285996335741	5	P14672,P31751	2
Insulin signaling in adipocytes normal condition	0.7492928052531338	1.6127360987528714	0.1068018542966657	1.0	0.6916285996335741	5	P14672,P31751	2
Neural crest cell migration in cancer	0.6517443829891443	1.5990730993446156	0.1098043611090613	1.0	0.6916285996335741	8	Q99523	1
S1p receptor signal transduction	0.6252986821495262	1.5841095954509734	0.1131687811730453	1.0	0.6916285996335741	9	Q9H0H5,P04899,Q13510,P31751	4
Familial hyperlipidemia type 4	0.7898329665405838	1.5633758281032788	0.117964222193414	1.0	0.7097470748214686	4	Q07954	1
Inhibition of exosome biogenesis and secretion by manumycin a in crpc cells	0.6432248177332794	1.555708005918485	0.1197775419701223	1.0	0.7097470748214686	8	P20339,P51148,P61020,P31943	4
P53 transcriptional gene network	0.642119144404633	1.550067999929637	0.1211251956570207	1.0	0.7097470748214686	8	P04066	1
Complement system	0.5659314890753475	1.5307217734671954	0.1258381701586266	1.0	0.7097470748214686	13	P98164,P17612,Q07021,P08754,P15529,P04899,P07942	7
Vitamin b12 metabolism	0.6130989027182362	1.5194538375559516	0.1286482992342308	1.0	0.7097470748214686	9	P04114,P01130,P98164	3
Allograft rejection	0.5874623004181045	1.5043361654764025	0.1324948315288572	1.0	0.7097470748214686	10	P04439,P10321	2
Lipid particles composition	0.938708620124549	1.4981185116764326	0.1341024623229889	1.0	0.7097470748214686	2	P04114	1
Regulatory circuits of the stat3 signaling pathway	0.5851465852376309	1.4915100646507342	0.1358276307743833	1.0	0.7097470748214686	10	P15260,P42345,P00533	3
Camkk2 pathway	0.5848159408305514	1.4896775478452744	0.1363090408597522	1.0	0.7097470748214686	10	P42345,O76024,Q13501,P09601	4
Transcription factors regulate mirnas related to cardiac hypertrophy	0.759425786471756	1.4362101105385046	0.1509425629142229	1.0	0.7397442663362056	4	P31751	1
Overlap between signal transduction pathways contributing to lmna laminopathies	0.5397771116460306	1.4321194607798964	0.1521096358975431	1.0	0.7397442663362056	14	O60725,P42167,P55209,O75844	4
Familial hyperlipidemia type 2	0.8580288061333038	1.4188394548177132	0.1559458270282609	1.0	0.7397442663362056	3	P04114	1
Ccl18 signaling pathway	0.5704241158759769	1.4096393943181116	0.1586461885456527	1.0	0.7397442663362056	10	Q86UE4,P11166,P19022,P00403	4
Small cell lung cancer	0.5257986290956892	1.4093117213315165	0.1587430144046187	1.0	0.7397442663362056	15	P07942,P06756,P31751	3
Metabolic pathway of ldl hdl and tg including diseases	0.7394609198560657	1.3523280642963025	0.1762703904226916	1.0	0.7430209417992328	4	P04114,P01130	2
Immune response to tuberculosis	0.8401551283680877	1.3475341404289558	0.1778082655855253	1.0	0.7430209417992328	3	P15260	1
Head and neck squamous cell carcinoma	0.5134489341173961	1.3300495135735733	0.1835019581336749	1.0	0.7430209417992328	15	P62942,P42345,P00533,P08069,P49815,P31751	6
Familial hyperlipidemia type 1	0.8350904281212077	1.3273288336239877	0.1843999298153491	1.0	0.7430209417992328	3	Q07954	1
Familial hyperlipidemia type 5	0.8350904281212077	1.3273288336239877	0.1843999298153491	1.0	0.7430209417992328	3	Q07954	1
Relationship between inflammation cox2 and egfr	0.6385190287778142	1.3269504674669617	0.184525068327624	1.0	0.7430209417992328	6	P31751	1
Ranklrank signaling pathway	0.4994101881029774	1.3072461676013545	0.1911291204825276	1.0	0.7437856270126948	16	Q13501	1
Cholesterol biosynthesis with skeletal dysplasias	0.6795623532404351	1.3004024335365096	0.1934630763112617	1.0	0.7437856270126948	5	Q15392,Q14739,Q16850	3
Glycerolipids and glycerophospholipids	0.6776826983658406	1.2919166802234037	0.1963860005468354	1.0	0.7437856270126948	5	Q9UG56,P48651,O14735	3
Type ii diabetes mellitus	0.6298203736793333	1.2848060451820502	0.1988600693733997	1.0	0.7437856270126948	6	P14672,Q15526	2
Adipogenesis	0.5045191179785312	1.272466845736696	0.2032072966619686	1.0	0.7437856270126948	15	Q9NZ45,O75844,P43490	3
Autosomal recessive osteopetrosis pathways	0.8209917851830573	1.271106049485221	0.2036909234921256	1.0	0.7437856270126948	3	P51798	1
Familial partial lipodystrophy fpld	0.6073300406491229	1.2611220613437042	0.2072648733080109	1.0	0.7437856270126948	7	O75844,P31751	2
Mitochondrial complex iii assembly	0.5850144703106582	1.2554528406288192	0.2093144175389416	1.0	0.7437856270126948	8	O14949,Q6DKK2,Q9UDW1	3
Extracellular vesiclemediated signaling in recipient cells	0.6035507175631032	1.2421753192066889	0.2141718837247002	1.0	0.7437856270126948	7	Q08431,P00533	2
Network map of sarscov2 signaling pathway	0.4583362302617132	1.2385807448838029	0.2155008025285125	1.0	0.7437856270126948	26	Q08380,O95067,Q07021,P42345,Q96B36,Q96J02,P07858,Q7Z434	8
Orexin receptor pathway	0.4859941894642937	1.2177381948484158	0.2233234776172958	1.0	0.7577942723643073	16	P11166,P01130,P14672	3
Monoamine transport	0.8049180327868792	1.2070922262794723	0.2273966283166006	1.0	0.7630420194623712	3	Q92692,O15127	2
Zinc homeostasis	0.8666011143887418	1.2004142039708166	0.2299785151499094	1.0	0.7674421168538414	2	Q8NEW0	1
Vitamin d metabolism	0.8006894330937309	1.1902751825189506	0.2339382517429451	1.0	0.772124065861961	3	P38435	1
Amyotrophic lateral sclerosis als	0.5289384498535694	1.176297985518618	0.2394758204934088	1.0	0.7796091473946298	10	P07196,P20339,Q9BUN8	3
Antiviral and antiinflammatory effects of nrf2 on sarscov2 pathway	0.6973208791845166	1.174791070189934	0.2400783136016575	1.0	0.7796091473946298	4	P09601	1
Nrp1triggered signaling pathways in pancreatic cancer	0.4959642296740347	1.1579859569973974	0.2468697672364028	1.0	0.7875121052336689	14	P31751,P00533	2
Myometrial relaxation and contraction pathways	0.4756285753644302	1.1482853019100034	0.2508508047543074	1.0	0.787815837654049	16	P10644,P16615,P0DP25	3
Mrna protein and metabolite inducation pathway by cyclosporin a	0.7872131147541015	1.1367699650013787	0.2556344622912943	1.0	0.7882397146984421	3	P08195,Q15758	2
Inclusion body myositis	0.7851465342198681	1.1285791732389714	0.259075400488745	1.0	0.7903108176525352	3	P05067	1
Hippomerlin signaling dysregulation	0.4350402297538417	1.0804863097418058	0.2799256799146103	1.0	0.812341361573203	21	P10644,P06756,P19022,P17612,P05556,P00533,P08069	7
Wnt signaling pathway	0.4969924873227971	1.0672949403098135	0.2858386721634638	1.0	0.8146163662634162	12	Q9BTU6,P49815,P42345	3
Nephrotic syndrome	0.4815769540533402	1.0671038361829996	0.2859249497480864	1.0	0.8146163662634162	14	O75844,Q14108,O00592	3
Omega3 omega6 fatty acid synthesis	0.6272965879265022	1.0640167130697709	0.2873211284102055	1.0	0.8147509932383292	5	Q15067,O95864,O95573,O60488	4
Vitamin a and carotenoid metabolism	0.7609574177186791	1.0330777274560137	0.3015675254466354	1.0	0.8393861076947825	3	Q8WTV0	1
Apoptosisrelated network due to altered notch3 in ovarian cancer	0.4556307869512864	1.0137750687805855	0.3106900942233181	1.0	0.8432257133518335	16	Q13501	1
Dopamine metabolism	0.8203867584398705	1.0127966563513948	0.311157298140877	1.0	0.8432257133518335	2	P21964	1
Embryonic stem cell pluripotency pathways	0.483413889967942	0.9860121632536571	0.3241271441882483	1.0	0.8521261494820475	12	P31751,P00533	2
7oxoc and 7betahc pathways	0.5309054057927108	0.9723822212769294	0.3308604332896636	1.0	0.8613780245989519	8	O15118	1
Spinal cord injury	0.4207072167160914	0.9660009530929556	0.3340437041181634	1.0	0.8622324670400457	22	O94813,Q08722,Q9NQC3	3
Hedgehog signaling pathway wp4249	0.6445023201972949	0.9530922895584072	0.3405433124307218	1.0	0.8684453744543471	4	P98164,P17612	2
Photodynamic therapyinduced nfe2l2 nrf2 survival signaling	0.7377049180327601	0.942138889644895	0.3461215361003895	1.0	0.8684453744543471	3	Q14145,P09601	2
Influence of laminopathies on wnt signaling	0.4855246799328952	0.9295403282361092	0.3526091355163947	1.0	0.8701916451364852	10	O60725,O75844,P14672	3
Metapathway biotransformation phase i and ii	0.4149918931635254	0.9288340644136708	0.3529750878450974	1.0	0.8701916451364852	21	P21964,Q16850,O15217,Q7LGA3,Q86UY6	5
Endometrial cancer	0.4635856002098338	0.90702534973203	0.364393392055087	1.0	0.8910672421104153	13	P31751	1
Factors and pathways affecting insulinlike growth factor igf1akt signaling	0.5158133572125382	0.8933749025246317	0.3716564382359735	1.0	0.9051632608650324	8	P08069,P05556,P42345	3
Oxidative phosphorylation	0.4146356933114568	0.8884871296880261	0.3742787758823831	1.0	0.9078890788472266	30	O75787,O75964,O96000,Q9Y6M9,Q15904,Q86Y39,P03886,O75438,P03915	9
Hair follicle development cytodifferentiation part 3 of 3	0.6277043371624207	0.8833133185550849	0.3770670097800228	1.0	0.9097792906823498	4	Q02487,P00533	2
Vasopressinregulated water reabsorption	0.451352975402945	0.8756999956087071	0.3811931477460342	1.0	0.9097792906823498	14	P20339,P51148,P61020,Q13561	4
Purinergic signaling	0.719016393442611	0.869900451697827	0.3843548086015129	1.0	0.9097792906823498	3	P04899,P08754	2
Nucleotidebinding oligomerization domain nod pathway	0.5109779133660078	0.8681057176141896	0.3853364613027308	1.0	0.9097792906823498	8	Q13685	1
Cannabinoid receptor signaling	0.6207393925503735	0.8545503608352751	0.3928001180822651	1.0	0.9118595569725294	4	P10644	1
Type ii interferon signaling ifng	0.5077829158807411	0.8514261716591275	0.3945326585871989	1.0	0.9118595569725294	8	Q03518,P15260	2
Nanomaterial induced apoptosis	0.5354195283284036	0.825761183199195	0.4089395774947046	1.0	0.9199072000468294	6	O95831	1
Angiopoietinlike protein 8 regulatory pathway	0.4003112148078476	0.7802450233622523	0.4352466657380205	1.0	0.9228956332562892	28	O75955,P42345,P14672,Q14254,P11166,P49815,O14654,P31751	8
Neuroinflammation	0.6889889702736267	0.7559870286995404	0.4496569728149744	1.0	0.936526936483602	3	P00403	1
Target of rapamycin tor signaling	0.4508702388887594	0.7329660626285499	0.4635791285605084	1.0	0.9409149444260896	10	P62942,Q9HB90,P49815,P42345	4
Splicing factor nova regulated synaptic proteins	0.4206864855705903	0.7268377303707421	0.4673253667143879	1.0	0.9409149444260896	15	Q9UNS2,P19022,Q06481	3
Vitamin d receptor pathway	0.4273717256649001	0.7243844513195657	0.4688297429019892	1.0	0.9409149444260896	14	P14672,Q96KA5,P48960	3
Insulin signaling	0.3903922228744368	0.7001605715624324	0.4838270318780928	1.0	0.9409149444260896	41	P10586,Q9H4M9,O75955,P42345,P14672,Q14254,P08069,P11166,O14654,P31751	10
Follicle stimulating hormone fsh signaling pathway	0.4948866998953752	0.6973932281010153	0.485556738354038	1.0	0.9409149444260896	7	P17612,P42345	2
Pi3kaktmtor signaling pathway and therapeutic opportunities	0.6670047736970617	0.6747744643745531	0.499819066384298	1.0	0.9499100632703243	3	P42345	1
Gastric cancer network 2	0.41255714903757	0.6743037630662891	0.5001182121191443	1.0	0.9499100632703243	15	Q86UE4,P00533	2
Primary focal segmental glomerulosclerosis fsgs	0.3811708965031605	0.6659832841332403	0.5054217849068812	1.0	0.9515767981985478	22	O00592,P06756,P19022,Q14108	4
Physiological and pathological hypertrophy of the heart	0.5008204791598372	0.6603777479614789	0.5090114482685744	1.0	0.9515767981985478	6	P63000,P61586,P40763,Q9P2K5,Q08209	5
Arrhythmogenic right ventricular cardiomyopathy	0.4163988901350233	0.6556894793212164	0.5120239394280266	1.0	0.9515767981985478	14	P06756,P19022,P16615,P05556,Q14126,P50402	6
Striated muscle contraction pathway	0.5687590181174207	0.644592859437771	0.5191910634556742	1.0	0.9591901713875792	4	P28289,P08670	2
Thyroid hormones production and peripheral downstream signaling effects	0.4029823151051108	0.6128032625980033	0.540006433335245	1.0	0.9745816132184064	15	P06756,P49815,P17612,P42345	4
Micrornas in cardiomyocyte hypertrophy	0.3701353164162613	0.5997689258831905	0.5486602453364609	1.0	0.9745816132184064	20	P08069,Q9P2K5,P42345,P31751	4
Mitochondrial complex i assembly model oxphos system	0.3744673816208842	0.5948121636939542	0.5519690359019647	1.0	0.9745816132184064	25	O96000,Q9Y6M9,Q9P0J0,O43676,P03886,O75438,O95169,P03915	8
Leukocyteintrinsic hippo pathway functions	0.5173884514435773	0.578216298729118	0.5631180961677269	1.0	0.9745816132184064	5	P63000,P51153,Q13043,P27348	4
Synaptic vesicle pathway	0.4020280844731249	0.5665865162205455	0.5709951380529663	1.0	0.9745816132184064	14	Q13277,P12235,Q96CW1,O00429	4
Nrf2 pathway	0.3649342232392136	0.5445324505934248	0.5860751240466306	1.0	0.9778712014479696	22	Q13501,P09601,P14672,P11166,O15217,Q15043	6
Vitamin dsensitive calcium signaling in depression	0.505365859833272	0.5278895834807134	0.5975759749041305	1.0	0.9795110961471052	5	P20020	1
Ectoderm differentiation	0.3559297274620254	0.5049660326626888	0.6135826936086022	1.0	0.9795110961471052	19	P16278,O00592	2
Sarscov2 and covid19 pathway	0.5310146585137632	0.5000457886811278	0.6170428366070861	1.0	0.9795110961471052	4	O14786,Q8WTV0	2
Estrogen signaling pathway	0.4627502461437448	0.484442294558248	0.6280720082938851	1.0	0.9795110961471052	6	P17612,Q02750,P31749,P28482,O14920	5
Malignant pleural mesothelioma	0.3321004077669397	0.469526947671158	0.638693027670822	1.0	0.9795110961471052	67	P06756,P19022,P08195,P05556,Q08722,Q07820,P42345,P00533,P08069,Q02487,O00592,P11166,P31751,P07942,Q14574	15
Regulation of apoptosis by parathyroid hormonerelated protein	0.4589665209846126	0.46746324454812	0.6401684830633649	1.0	0.9795110961471052	6	Q9BXK5	1
Omega9 fatty acid synthesis	0.4509353462422059	0.4318018136138448	0.6658854612826275	1.0	0.9795110961471052	6	O95573,O00767,O95864,P33121,O60488	5
Nanoparticlemediated activation of receptor signaling	0.4248824452452148	0.4309071454308271	0.6665358877042165	1.0	0.9795110961471052	8	P00533	1
Dna damage response only atm dependent	0.3609683825609417	0.4303026208213859	0.6669755208993886	1.0	0.9795110961471052	17	P01130	1
Eicosanoid synthesis	0.6601114388725193	0.428923461857923	0.6679789254484452	1.0	0.9795110961471052	2	P09960	1
Tyrobp causal network in microglia	0.5104248906744155	0.4253082502419359	0.6706119800484138	1.0	0.9795110961471052	4	P61916	1
Folate metabolism	0.3715481087438639	0.4153665728829376	0.6778735731614072	1.0	0.9795110961471052	15	P04114,P01130,Q8WTV0	3
Hepatitis b infection	0.3500264749426656	0.4114750317485565	0.6807242458627387	1.0	0.979885561722635	25	Q15904,Q9Y277	2
Nonsmall cell lung cancer	0.3747695787565608	0.4017482203601388	0.6878693328292029	1.0	0.979885561722635	14	P31751	1
Drug induction of bile acid pathway	0.6506063585709783	0.4001402204063146	0.6890532416985582	1.0	0.979885561722635	2	Q06520	1
Nuclear receptors in lipid metabolism and toxicity	0.6506063585709538	0.4001402204062425	0.6890532416986113	1.0	0.979885561722635	2	P28288	1
Tgfbeta signaling pathway	0.3526001031469378	0.3886091568297575	0.6975652920302775	1.0	0.9890362356485624	33	Q96J02,P05556,P05067,Q96PU5	4
Complement and coagulation cascades	0.5766120770818973	0.3713916788335088	0.7103458224366339	1.0	0.992054765907683	3	P15529	1
H19 action rbe2f1 signaling and cdkbetacatenin activity	0.4359234183571067	0.3666808041340195	0.7138571267818459	1.0	0.992054765907683	6	Q16527	1
Notch signaling pathway	0.3799045277419427	0.3608554738836996	0.7182074906272369	1.0	0.992054765907683	11	Q92542	1
Arachidonate epoxygenase epoxide hydrolase	0.6368403802032219	0.3601220350532738	0.7187558751675762	1.0	0.992054765907683	2	P34913	1
Glycosylation and related congenital defects	0.3818707753348827	0.3562914876598813	0.721622283483047	1.0	0.9928470597352174	10	Q9BV10,Q9BT22,Q9Y5P6,Q2TAA5,Q9H0U3	5
Neuroinflammation and glutamatergic signaling	0.3369726102519064	0.3244471348885355	0.7455995395115056	1.0	1.0	24	P09622,P15260,P11166	3
T cell receptor and costimulatory signaling	0.4804854050508339	0.3233576313339398	0.7464244126831407	1.0	1.0	4	P49840,Q08209,P48729	3
Progeriaassociated lipodystrophy	0.3857386617413525	0.3085895559697726	0.7576337665040913	1.0	1.0	9	O75844	1
Triacylglyceride synthesis	0.5544262295081933	0.3073925559349643	0.7585445935994215	1.0	1.0	3	O00116,Q99943	2
Hair follicle development organogenesis part 2 of 3	0.5499303727562399	0.2950535298314504	0.7679529879973175	1.0	1.0	3	P05556	1
Focal adhesion pi3kaktmtorsignaling pathway	0.3402265320533773	0.2783080809453814	0.7807758733778933	1.0	1.0	41	P06756,P05556,P14672,P42345,P08069,P00533,P11166,P61019,O14654,P07942,P31751	11
Caloric restriction and aging	0.4402050504237926	0.2756438521609506	0.7828216247892004	1.0	1.0	5	P43490	1
Selenium micronutrient network	0.3604127596214891	0.2744908835278578	0.7837074085717128	1.0	1.0	12	P04114,P01130	2
G protein signaling pathways	0.346489942589683	0.2658576609305184	0.7903488336004645	1.0	1.0	15	P10644,P04899,P17612,P08754	4
Pi3kakt signaling pathway	0.338646738182492	0.265666583053352	0.7904960016270492	1.0	1.0	40	P06756,P05556,Q07820,P42345,P00533,P08069,P07942,P31751	8
Sulfation biotransformation reaction	0.4621187274516081	0.2655092591998454	0.790617177939952	1.0	1.0	4	Q06520,P00390,P11413	3
Ras signaling	0.3356515051886627	0.2635974037033215	0.7920901593364986	1.0	1.0	32	P20339,P17612,P61020,P00533,P0DP25,P51148,P11233,P31751	8
Tgfbeta signaling in thyroid cells for epithelialmesenchymal transition	0.4220266811588908	0.21360837043069	0.8308524713969312	1.0	1.0	5	P19022	1
Mammary gland development pathway pregnancy and lactation stage 3 of 4	0.3920572609366161	0.1911391877703267	0.8484165461835507	1.0	1.0	6	P18031,P00533	2
Phase i biotransformations non p450	0.5039836342390711	0.1824655555033809	0.855217383291438	1.0	1.0	3	P38571	1
Autophagy	0.3883426927235624	0.1775045647369254	0.8591120800266032	1.0	1.0	6	P42345,Q9Y4P8	2
Map3k1 role in promoting and blocking gonadal determination	0.5003278688524566	0.1746295349442683	0.861370739643488	1.0	1.0	3	P35222,P61586	2
Glycogen synthesis and degradation	0.3232527708745475	0.1616602736206255	0.8715733900133025	1.0	1.0	16	P52789,P0DP25	2
Cardiac hypertrophic response	0.3338630177754303	0.1407788615571635	0.8880446427719018	1.0	1.0	12	P31751	1
Mirna regulation of prostate cancer signaling pathways	0.3686802363755685	0.1355441959384514	0.8921816233447202	1.0	1.0	7	P35222,Q02750,P42345,Q8NCF5,P28482,P62993	6
Angiogenesis	0.4803278688524663	0.1348437103130983	0.8927354455852654	1.0	1.0	3	Q05397,P28482	2
Initiation of transcription and translation elongation at the hiv1 ltr	0.3683519369665131	0.1343411460484151	0.8931328182719942	1.0	1.0	7	Q92769,Q08209,P50750,Q13547,P18615,Q8IXH7	6
Thyroid stimulating hormone tsh signaling pathway	0.3060955518945714	0.1248276633623664	0.9006599864806861	1.0	1.0	18	P62753,P11802,Q14344,P27695,P40763,Q14160,Q15418,Q02750,P42345,P08754,P08069,P42224,P04899,P31749,P28482,P24941,P63096	17
Hippoyap signaling pathway	0.5260570304817999	0.122035489177529	0.9028709120124736	1.0	1.0	2	Q13043	1
Bdnftrkb signaling	0.3537116560683669	0.1183131700746827	0.9058195224829004	1.0	1.0	8	P42345	1
Wnt signaling in kidney disease	0.5168797115699667	0.1094538115893897	0.912842554604662	1.0	1.0	2	P35222	1
Serotonin htr1 group and fos pathway	0.3603403680253864	0.1055933482257589	0.91590500259235	1.0	1.0	7	P04899,P08754	2
Mapk and nfkb signaling pathways inhibited by yersinia yopj	0.4622950819672204	0.1034979773258335	0.917567754735088	1.0	1.0	3	O14920,P28482	2
Vitamin d in inflammatory diseases	0.4622950819672203	0.1034979773258332	0.9175677547350882	1.0	1.0	3	O14920,Q08209	2
Thymic stromal lymphopoietin tslp signaling pathway	0.3271550220465017	0.1007036580582285	0.9197857074285424	1.0	1.0	11	Q9BTU6	1
Neural crest differentiation	0.3634301704396601	0.0920639772790255	0.926647208831596	1.0	1.0	6	P19022	1
Somatroph axis gh and its relationship to dietary restriction and aging	0.3875910970595399	0.0770164072738196	0.9386104926180108	1.0	1.0	4	P42345	1
Regucalcin in proximal tubule epithelial kidney cells	0.3516086671043944	0.0756499017497625	0.9396976343236628	1.0	1.0	7	P42574,Q13283,P42345,Q8NE86,P31749,P28482	6
Praderwilli and angelman syndrome	0.3684383202099724	0.0598425330392189	0.952281049791166	1.0	1.0	5	P11802,Q15154,Q7L576,O95714	4
Pregnane x receptor pathway	0.366797900262464	0.05590463609752	0.9554177775363206	1.0	1.0	5	Q06520,P08183,P62195,Q99615	4
Nodlike receptor nlr signaling pathway	0.4621435594886796	0.0551254541135315	0.95603851752279	1.0	1.0	2	O14920	1
Altered glycosylation of muc1 in tumor microenvironment	0.4621435594886796	0.0551254541135315	0.95603851752279	1.0	1.0	2	O14920	1
Ovarian infertility	0.4575549000327634	0.0520109626759746	0.9585199582859096	1.0	1.0	2	P11802	1
Liver x receptor pathway	0.4503441494591832	0.0475044159180791	0.9621112109173172	1.0	1.0	2	O00767	1
Nocgmppkg mediated neuroprotection	0.3664252200282965	0.0388114703040504	0.969040699745692	1.0	1.0	4	P07196,Q13555	2
Benzoapyrene metabolism	0.333988856112743	0.0181993136692253	0.9854798501591562	1.0	1.0	2	P07099	1
Hostpathogen interaction of human coronaviruses apoptosis	0.3512627090849463	0.0157501522713423	0.9874337162218904	1.0	1.0	4	Q07820,P31749,P42574	3
Brainderived neurotrophic factor bdnf signaling pathway	0.3058204790543557	0.0120489925198822	0.9903865275068582	1.0	1.0	42	Q13501,Q99523,Q96P70	3
Srebf and mir33 in cholesterol and lipid homeostasis	0.3318439627028109	0.0006495234232512	0.9994817553251476	1.0	1.0	6	P01130	1